Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome
Year: 2014
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: JAMA
Authors: Michelle L. O’Donoghue, Eugene Braunwald, Harvey D. White, Dylan P. Steen, Mary Ann Lukas, Elizabeth Tarka, P. Gabriel Steg, Judith S. Hochman, Christoph Bode, Aldo P. Maggioni, KyungAh Im, Jennifer B. Shannon, Richard Y. Davies, Sabina A. Murphy, Sharon E. Crugnale, Stephen D. Wiviott, Marc P. Bonaca, David F. Watson, W. Douglas Weaver, Patrick W. Serruys, Christopher P. Cannon
Institutions: Brigham and Women's Hospital, Thrombolysis in Myocardial Infarction Study Group, University of Auckland, Auckland City Hospital, GlaxoSmithKline (United States), Royal Brompton Hospital, Assistance Publique – Hôpitaux de Paris, Hôpital Bichat-Claude-Bernard, Université Paris Diderot, NYU Langone Health, University of Freiburg, Associazione Nazionale Medici Cardiologi Ospedalieri, Henry Ford Health, Henry Ford Hospital, Imperial College London
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2113187337